Obsidian Therapeutics
Biotechnology company developing controllable cell and gene therapies using its proprietary cytoDRiVE platform to provide precise, tunable control over therapeutic proteins expressed in engineered cells.
Website
https://www.obsidiantx.comLocation
Cambridge, Massachusetts, USA
Founded
2015
Investors
1
Categories
biotech, cell-therapy, gene-therapy, regulated-therapeutics
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Novo Holdings | Hellerup, Denmark | biotech-focused | seedseries-a+3 | 13 |